Benralizumab at @ mg and @ mg doses seemed to reduce asthma exacerbations in adults with uncontrolled eosinophilic asthma and baseline blood eosinophils of at least @ cells per L , possibly due to targeting of the interleukin @ receptor rather than interleukin @ ligand .